Jointown Pharmaceutical Group Co., Ltd.( abbr. as Jointown below), initially set up in 1999 by following the same step of the new policy into effect which has enabled private capital to enter pharmaceutical distribution, is now a leading public listed enterprise (Shanghai Stock Exchange, in Nov.2010, Share code 600998) in China pharmaceutical commercial industry. Jointown has the core business related to wholesale and retail of products including medicines and medical appliances, Medicine R&D and production, and relevant value-added services. Jointown has been the 3rd largest China pharmaceutical commercial enterprise, the largest China private pharmaceutical commercial enterprise and one of the China Top 500 Enterprises for 6 years successively. To Dec. 31,2010, Jointown has total assets RMB81 Billion, 7412 employees, over 70 subsidiaries, and 709 regular and franchise chain pharmacies. Total revenue in 2012 is RMB 38 Billion. Jointown has a well-structured portfolio covering